Literature DB >> 26631684

Mothers' Continuing Bond With the Baby: The Case of Feticide.

Ronit D Leichtentritt1, Michal Mahat-Shamir2.   

Abstract

The nature of the ongoing bond maintained by the bereaved with the deceased has attracted considerable attention, but studies have generally ignored postdeath relationships when loss occurs in utero. The goal of this research was to reach an interpretive understanding of the continuing bond experience among Israeli mothers who underwent feticide, examining the strategies they use in maintaining a postdeath relationship with a child they did not know, whose death they chose and witnessed, within a social context that ignores their loss and forces them to silence their grief. The results highlight two themes: (a) strategies for relinquishing connection with the baby and (b) strategies for maintaining a postdeath relationship. These processes partially correspond with two theoretical views that shed light on interpretation of the results: the dual process of coping with bereavement and relational dialectic theory. Implications of the results to the practice of health providers are outlined.

Entities:  

Keywords:  Gadamer; Hermeneutic; Israel; abortion; bereavement; grief; mothers

Mesh:

Year:  2016        PMID: 26631684     DOI: 10.1177/1049732315616626

Source DB:  PubMed          Journal:  Qual Health Res        ISSN: 1049-7323


  3 in total

1.  The 2015 Pregnancy Summit, London, UK.

Authors:  Cherynne Johansson
Journal:  Womens Health (Lond)       Date:  2016-02-22

2.  Termination of pregnancy for fetal anomaly: a systematic review of the healthcare experiences and needs of parents.

Authors:  Suzanne Heaney; Mark Tomlinson; Áine Aventin
Journal:  BMC Pregnancy Childbirth       Date:  2022-05-26       Impact factor: 3.105

3.  Double-Layer Masking of Suffering After Pregnancy Loss: A Grounded Theory Study from a Male Perspective.

Authors:  Sara Fernández-Basanta; Carmen Coronado; María-Jesús Movilla-Fernández
Journal:  J Midwifery Womens Health       Date:  2022-03-11       Impact factor: 2.891

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.